XJPX
7775
Market cap76mUSD
Oct 09, Last price
429.00JPY
1D
2.14%
1Q
1.66%
Jan 2017
-46.64%
IPO
164.81%
Name
Daiken Medical Co Ltd
Chart & performance
P/E
13.36
P/S
1.20
EPS
32.12
Div yield, %
5.48%
Shrs. gr., 5y
—
Rev. gr., 5y
5.53%
Revenues
10.29b
+3.41%
Net income
923m
-15.94%
CFO
568m
-49.35%
Dividend
Mar 30, 202711 JPY/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Daiken Medical Co., Ltd. is a global developer and provider of healthcare devices and equipment, serving both the Japanese market and international clientele. Its extensive product catalog includes syringe pumps, disposable and portable infusion pumps, endobronchial blocker tubes, a range of suction accessories (containers, connecting tubes, and tips), medical hand washing machines, disposable medical towels, sterilize mats, and wet disinfectant mats. Additionally, the company engages in the trade of other medical apparatus. All its offerings are marketed under the COOPDECH brand. Established in 1968, Daiken Medical Co., Ltd. maintains its headquarters in Izumi, Japan.
Key people
Keiichi Yamada
President, Chief Executive Officer, Chief Director of Technology, Chief Director of Administration, Representative Director · since 2021
Masayuki Yamada
Executive Director · since 2016
Takanori Mizuguchi
Executive Officer, Director of Administration · since 2013
Shinji Yanagihori
Director of Sales, Director · since 2012
Yoshihisa Koga
Independent Director · since 2010
Valuation
Title JPY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026‑03 | 2025‑03 | 2024‑03 | 2023‑03 | 2022‑03 | 2021‑03 | 2020‑03 | 2019‑03 | 2018‑03 | 2017‑03 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||